Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crawford & Company A | CRD-A | Nov 22, 2024 | 11.84 | +0.34 |
Crawford & Company B | CRD-B | Nov 22, 2024 | 11.10 | +2.78 |
Creative Media & Community Trust | CMCT | Nov 22, 2024 | 0.22 | -9.11 |
Creative Medical Technology | CELZ | Nov 22, 2024 | 2.54 | -0.20 |
Creative Realities | CREX | Nov 22, 2024 | 3.45 | +2.37 |
Credicorp | BAP | Nov 22, 2024 | 197.32 | -0.67 |
Credit Acceptance | CACC | Nov 22, 2024 | 473.10 | +2.84 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Nov 22, 2024 | 26.85 | +0.35 |
Credit Suisse Ag | SLVO | Nov 22, 2024 | 78.99 | +1.48 |
Credit Suisse Ag | GLDI | Nov 22, 2024 | 157.00 | +1.40 |
Credit Suisse Asset Management Income Fund | CIK | Nov 22, 2024 | 2.99 | +0.34 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Nov 22, 2024 | 65.29 | +1.19 |
Credit Suisse High Yield Bond Fund | DHY | Nov 22, 2024 | 2.23 | +0.45 |
Credo Technology | CRDO | Nov 22, 2024 | 45.84 | -0.95 |
Crescent Capital BDC | CCAP | Nov 22, 2024 | 19.22 | +0.84 |
Crescent Energy | CRGY | Nov 22, 2024 | 15.28 | +0.66 |
Cresud A ADR | CRESY | Nov 22, 2024 | 11.37 | +1.16 |
Crexendo | CXDO | Nov 22, 2024 | 5.24 | +4.18 |
CRH | CRH | Nov 22, 2024 | 101.40 | +0.90 |
Cricut A | CRCT | Nov 22, 2024 | 5.10 | -1.54 |
Crinetics Pharmaceuticals | CRNX | Nov 22, 2024 | 56.06 | -1.70 |
CRISPR Therapeutics | CRSP | Nov 22, 2024 | 47.88 | +3.43 |
Criteo ADR | CRTO | Nov 22, 2024 | 39.95 | +3.47 |
Critical Metals | CRML | Nov 22, 2024 | 6.20 | +5.80 |
Crocs | CROX | Nov 22, 2024 | 106.08 | +4.19 |
Cronos Group | CRON | Nov 22, 2024 | 2.08 | +1.46 |
Cross Country Healthcare | CCRN | Nov 22, 2024 | 10.34 | -0.39 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 22, 2024 | 10.96 | -1.26 |
CrossAmerica Partners LP Unit | CAPL | Nov 22, 2024 | 20.32 | +0.49 |
CrossFirst Bankshares | CFB | Nov 22, 2024 | 17.96 | +2.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.